China Drug Safety: SFDA Issues Excipients Regulation Stressing Manufacturer Role
This article was originally published in PharmAsia News
Executive Summary
Drawing lessons from the recent chromium capsule scandal, China issues a new regulation on excipients that requires drug manufacturers to step up quality control.